Can humans endure long-term living far from our home planet? Maybe, according to a new theory that describes the need for gravity, oxygen, obtaining water, developing agriculture and handling waste.
Using a biomaterials-based organoid, a multi-institution team led by Matt DeLisa of Cornell Engineering was able to assess the strength of the immune response to a glycoengineered vaccine in days, instead of months.
People with autism spectrum disorder can be classified into four distinct subtypes based on their brain activity and behavior, according to a study from Weill Cornell Medicine investigators.
A Cornell multidisciplinary research center that studies chronic fatigue syndrome has received a five-year, $9.5 million grant from the National Institutes of Health – funding that will enable experts to continue work on the mysterious and debilitating condition.
A team has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including omicron. Their discovery could lead to more potent vaccines and new antibody-based treatments.
Through increased collaboration between Cornell Health and Weill Cornell Medicine, this spring two new partnerships – with another on the way – will enhance and expand services to the Ithaca campus community to better meet the needs of Cornell students.
Ocular drift, a very subtle and seemingly random type of eye movement, can be influenced by prior knowledge of the expected visual target, suggesting a surprising level of cognitive control over the eyes, according to a study led by Weill Cornell Medicine neuroscientists.
New research suggests a strategy to ward off age-related weight gain, which could prevent obesity and associated health disorders like Type 2 diabetes, heart disease and chronic inflammation.
Hospitals have begun using “decision support tools” powered by artificial intelligence that can diagnose disease, suggest treatment or predict a surgery’s outcome.
